Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis
Related Experiment Video
Updated: Oct 29, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
S B Jakowlew1, T W Moody, L You
1Department of Cell and Cancer Biology, Medicine Branch, National Cancer Institute, Rockville, Maryland 20850, USA.
Abstract:
Transforming growth factor-beta (TGF-beta) is a growth modulator that inhibits the proliferation of many epithelial cells through interaction with its receptors, the type I and type II receptors (TGF-beta RI and RII) by activating their serine/threonine kinase activities. Loss of growth inhibition by TGF-beta is thought to contribute to the development of many types of tumors. To examine the roles of TGF-beta1, -beta2, and -beta3 and TGF-beta RI and RII in chemically induced mouse lung tumorigenesis, we used immunohistochemical and in situ hybridization analyses to measure the expression of their proteins and mRNAs in A/J mice treated with the carcinogen urethane to induce lung adenomas. Immunostaining for the TGF-beta ligands and receptors was detected in the epithelia of the bronchioles of untreated and treated A/J mice at similar levels. Immunostaining for the TGF-beta ligands and receptors was also detected in adenomas by 2 mo. While immunostaining for TGF-beta1, -beta2, and -beta3 and TGF-beta RI in adenomas was detected at levels comparable to those in bronchioles, immunostaining for TGF-beta RII was less intense in adenomas than in bronchioles. Decreased immunostaining for TGF-beta RII in adenomas persisted for at least 8 mo after exposure to urethane, whereas immunostaining for TGF-beta1, -beta2, and -beta3 and TGF-beta RI persisted at levels comparable to those in normal bronchioles. In situ hybridization studies conducted with TGF-beta receptor riboprobes showed a corresponding reduction in expression of TGF-beta RII mRNA but not of TGF-beta RI mRNA in adenomas compared with expression in bronchioles. Expression of TGF-beta RII mRNA was also examined in non-tumorigenic and tumorigenic mouse lung cells; expression of TGF-beta RII mRNA was lower in the tumorigenic cells derived from urethane-induced lung tumors. These data suggest that a decrease in expression of TGF-beta RII may contribute to autonomous cell growth and may play an important role in mouse lung carcinogenesis induced by urethane.
Insights
Decreased expression of transforming growth factor-beta type II receptor (TGF-beta RII) in lung adenomas suggests its role in urethane-induced mouse lung cancer. This loss of TGF-beta RII may drive autonomous cell growth.
Area of Science:
- Oncology
- Molecular Biology
- Carcinogenesis
Background:
- Transforming growth factor-beta (TGF-beta) inhibits epithelial cell proliferation via TGF-beta receptors (RI and RII).
- Loss of TGF-beta growth inhibition is implicated in tumor development.
- Understanding TGF-beta signaling in lung cancer is crucial.
Purpose of the Study:
- To investigate the roles of TGF-beta1, -beta2, -beta3, TGF-beta RI, and TGF-beta RII in urethane-induced mouse lung tumorigenesis.
- To analyze the expression patterns of these molecules during lung cancer development.
Main Methods:
- Immunohistochemical analysis of TGF-beta ligands and receptors in A/J mouse lung tissues.
- In situ hybridization to detect mRNA expression of TGF-beta RI and RII.
- Comparison of expression in normal bronchioles versus urethane-induced lung adenomas and derived cell lines.
Main Results:
- TGF-beta ligands and TGF-beta RI were expressed at comparable levels in normal bronchioles and adenomas.
- TGF-beta RII protein and mRNA expression were significantly reduced in lung adenomas compared to normal bronchioles.
- Lower TGF-beta RII mRNA levels were observed in tumorigenic lung cells derived from urethane-induced tumors.
Conclusions:
- A decrease in TGF-beta RII expression is associated with urethane-induced mouse lung carcinogenesis.
- Reduced TGF-beta RII may contribute to autonomous cell proliferation in lung tumors.
- TGF-beta RII downregulation is a potential mechanism in lung cancer development.
